Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Stewart JD, Marchan R, Lesjak MS, Lambert J, Hergenroeder R, Ellis JK, Lau CH, Keun HC, Schmitz G, Schiller J, Eibisch M, Hedberg C, Waldmann H, Lausch E, Tanner B, Sehouli J, Sagemueller J, Staude H, Steiner E, Hengstler JG. Stewart JD, et al. Among authors: tanner b. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8155-60. doi: 10.1073/pnas.1117654109. Epub 2012 May 8. Proc Natl Acad Sci U S A. 2012. PMID: 22570503 Free PMC article.
Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning 1 H NMR spectroscopy.
Gogiashvili M, Horsch S, Marchan R, Gianmoena K, Cadenas C, Tanner B, Naumann S, Ersova D, Lippek F, Rahnenführer J, Andersson JT, Hergenröder R, Lambert J, Hengstler JG, Edlund K. Gogiashvili M, et al. Among authors: tanner b. NMR Biomed. 2018 Feb;31(2). doi: 10.1002/nbm.3862. Epub 2017 Dec 5. NMR Biomed. 2018. PMID: 29206323
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.
Edlund K, Madjar K, Lebrecht A, Aktas B, Pilch H, Hoffmann G, Hofmann M, Kolberg HC, Boehm D, Battista M, Seehase M, Stewen K, Gebhard S, Cadenas C, Marchan R, Brenner W, Hasenburg A, Koelbl H, Solbach C, Gehrmann M, Tanner B, Weber KE, Loibl S, Sachinidis A, Rahnenführer J, Schmidt M, Hengstler JG. Edlund K, et al. Among authors: tanner b. Clin Cancer Res. 2021 Apr 15;27(8):2148-2158. doi: 10.1158/1078-0432.CCR-20-2662. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542080 Clinical Trial.
ErbB-3 predicts survival in ovarian cancer.
Tanner B, Hasenclever D, Stern K, Schormann W, Bezler M, Hermes M, Brulport M, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Steiner E, Sehouli J, Edelmann J, Läuter J, Lessig R, Krishnamurthi K, Ullrich A, Hengstler JG. Tanner B, et al. J Clin Oncol. 2006 Sep 10;24(26):4317-23. doi: 10.1200/JCO.2005.04.8397. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896008
Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.
Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch H, Hengstler JG. Schmidt M, et al. Among authors: tanner b. Br J Cancer. 2007 Jan 29;96(2):241-7. doi: 10.1038/sj.bjc.6603538. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211474 Free PMC article.
Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Steiner E, Eicher O, Sagemüller J, Schmidt M, Pilch H, Tanner B, Hengstler JG, Hofmann M, Knapstein PG. Steiner E, et al. Among authors: tanner b. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):197-203. doi: 10.1046/j.1525-1438.2003.13021.x. Int J Gynecol Cancer. 2003. PMID: 12657124
223 results